Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifting risk profile in radical prostatectomy over 18 years: A bicentric French study of 8,358 patients.

The French journal of urology·2026
Same author

Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.

The French journal of urology·2026
Same author

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

European urology oncology·2026
Same author

Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit All.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same author

Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG.

The French journal of urology·2026
Same author

[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care].

Bulletin du cancer·2026

Related Experiment Video

Updated: Dec 19, 2025

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

4.3K

[ABO-incompatible renal transplantation].

Yann Neuzillet1, Eric Lechevallier

  • 1Service d'Urologie, Hôpital Salvator, Marseille, France. yann.neuzillet@wanadoo.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|June 1, 2006
PubMed
Summary

ABO-incompatible kidney transplants are becoming more common due to legal changes. This review assesses the risks and immunological factors to determine if these transplants yield satisfactory outcomes for patients.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.5K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.4K

Related Experiment Videos

Last Updated: Dec 19, 2025

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

4.3K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.5K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.4K

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • The French Bioethics Law revision in 2004 has spurred growth in living donor kidney transplantation.
  • ABO blood group incompatibility poses a significant challenge in matching recipients with suitable living donors.
  • Ensuring satisfactory outcomes requires mastering the risks associated with ABO-incompatible organ transplantation.

Purpose of the Study:

  • To evaluate the safety and efficacy of ABO-incompatible kidney transplantation.
  • To review current knowledge on the immunological mechanisms underlying ABO-incompatible transplants.
  • To determine the level of evidence supporting ABO-incompatible transplantation through a systematic literature review.

Main Methods:

  • Conducted a review of ABO-incompatible transplantations.
  • Analyzed the current understanding of immunological mechanisms involved.
  • Performed a systematic review of international literature on the topic.

Main Results:

  • The study synthesizes existing data on ABO-incompatible transplantation.
  • It examines the immunological challenges and strategies to overcome them.
  • The level of proof for satisfactory outcomes is being defined.

Conclusions:

  • ABO-incompatible kidney transplantation is a growing field with evolving protocols.
  • Understanding immunological risks is crucial for successful transplantation.
  • Further evidence is needed to fully establish the mastery of risks for satisfactory results.